NCT01426204View on ClinicalTrials.gov

Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)

UnknownOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

August 31, 2013

Conditions
Hepatitis C
Sponsors

Lead Sponsor

Closter Pharma
All Listed Sponsors
lead

Closter Pharma

INDUSTRY

NCT01426204 - Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1) | Biotech Hunter | Biotech Hunter